Search Results 1001-1010 of 17739 for corticosteroid

1. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer - Mayo Clinic

   Notes: Patients previously treated or untreated for this condition who are asymptomatic in the absence of corticosteroid and anti-epileptic therapy are allowed.

2. A Study of the Safety and Effectiveness of RoActemra/Actemra (Tocilizumab) for Patients with Giant Cell Arteritis - Mayo Clinic

   Corticosteroids for conditions other than GCA; IV corticosteroids within 6 weeks of baseline. History of severe allergic reactions to monoclonal antibodies ...

3. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

   Inadequate response with, loss of response to, or intolerance to corticosteroids, immunomodulators, or Tumor necrosis factor-alpha (TNF-α) antagonists.

4. Sepsis - Symptoms & causes - Mayo Clinic

   A condition that requires treatment with corticosteroids, which can lower immune response. Complications. As sepsis worsens, vital organs, such as the brain ...

5. A Study to Determine Recommended Dose, Regimen and Evaluate the Safety and Preliminary Effectiveness of CC-92480 in Combination With Standard Treatments in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) - Mayo Clinic

   Participation eligibility · Intranasal, inhaled, topical or local corticosteroid injections (e.g., intra-articular injection); · Systemic corticosteroids at doses ...

6. Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   About this study. This randomized phase III trial studies bortezomib, lenalidomide, and dexamethasone to see how well it works compared to carfilzomib, ...

7. A Study of Pembrolizumab Alone or Combined with CC-486 for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer - Mayo Clinic

   ... corticosteroids or immunosuppressive drugs) ... Replacement therapy (e.g. thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or ...

8. A Study to Assess the Effectiveness, Safety and Tolerability of Dupilumab in Patients with Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) with Type 2 Inflammation - Mayo Clinic

   *Moderate exacerbations are recorded by the investigator and defined as AECOPD that require either systemic corticosteroids (intramuscular (IM), intravenous ...

9. Focal segmental glomerulosclerosis (FSGS) - Diagnosis and treatment - Mayo Clinic

   For primary FSGS , these medicines may stop the immune system from damaging the kidneys. These medicines include corticosteroids. They can have serious side ...

10. Hemang Yadav, M.B.B.S. - Mayo Clinic Faculty Profiles

    Corticosteroids have been shown to improve survival in severely ill patients with COVID-19 pneumonia. Dr. Yadav is the principle investigator for the ...